¶ MBD4 Gene - Methyl-CpG Binding Domain Protein 4
| MBD4 |
|---|
| Full Name | Methyl-CpG Binding Domain Protein 4 |
| Gene Symbol | MBD4 |
| Chromosomal Location | 3q21.3 |
| NCBI Gene ID | 8930 |
| OMIM | 603695 |
| Ensembl ID | ENSG00000129071 |
| UniProt ID | Q9C7B4 |
| Category | Gene |
| Path | /genes/mbd4 |
MBD4 (Methyl-CpG Binding Domain Protein 4), also known as MED1 (Methyl-CpG Binding Endonuclease 1), is a unique member of the methyl-CpG binding domain family. Unlike other MBD proteins that primarily function as transcriptional repressors, MBD4 combines DNA binding capability with enzymatic activity in base excision repair (BER). Located on chromosome 3q21.3, MBD4 plays critical roles in maintaining genomic integrity and preventing mutations at methylated CpG sites.
¶ Protein Structure and Function
MBD4 possesses a distinctive dual-domain architecture that enables its specialized functions:
¶ Methyl-CpG Binding Domain (MBD)
The N-terminal MBD domain (amino acids 80-160) mediates sequence-specific binding to methylated CpG dinucleotides. This domain recognizes the methylated cytosine residues and directs MBD4 to regions of the genome prone to deamination-induced mutations.
¶ C-terminal Glycosylase Domain
The C-terminal region contains a DNA glycosylase domain that excises mismatched thymine bases arising from deamination of 5-methylcytosine. This enzymatic activity is essential for:
- Correction of G:T mismatches at methylated CpG sites
- Prevention of C→T transition mutations
- Maintenance of genomic stability
¶ Additional Domains
- PWWP Domain: Present in some isoforms, involved in chromatin interactions
- Proline-Rich Region: Mediates protein-protein interactions
MBD4 is a key player in the base excision repair pathway specifically targeting deamination damage:
5-methylcytosine (5mC) spontaneously deaminates to form thymine, creating G:T mismatches at CpG sites. These mismatches, if unrepaired, lead to C→T transition mutations during DNA replication. CpG dinucleotides are mutation hotspots in the human genome.
- Damage Recognition: MBD4 binds to methylated CpG sites through its MBD domain
- Mismatch Detection: Upon encountering a G:T mismatch, MBD4's glycosylase domain excises the mismatched thymine
- Base Excision: The glycosylase cleaves the N-glycosidic bond, creating an abasic site
- Repair Completion: Subsequent BER enzymes (AP endonuclease, DNA polymerase, ligase) complete the repair
MBD4 is ubiquitously expressed with highest levels in:
- Brain: Particularly in the hippocampus, cerebral cortex, and cerebellum
- Testis: High expression in spermatogonia
- Bone marrow: Moderate expression
- Epithelial tissues: Including intestinal epithelium
In the brain, MBD4 is expressed in neurons and glial cells, with particular enrichment in regions with high synaptic plasticity.
MBD4 has several connections to neurodegenerative processes:
Neurons are post-mitotic cells that must survive for decades without cell division. They accumulate DNA damage over time, including:
- Oxidative damage
- Spontaneous deamination events
- Replication-independent DNA lesions
MBD4 contributes to maintaining genomic integrity in neurons through its repair function. Deficiencies in DNA repair mechanisms are implicated in neurodegenerative diseases.
- DNA damage accumulation: Increased DNA damage has been documented in AD brains
- MBD4 expression: Altered MBD4 expression has been reported in Alzheimer's disease models
- APOE interaction: MBD4 may interact with APOE, a major AD risk factor
- Epigenetic changes: MBD4 dysfunction may contribute to the epigenetic dysregulation observed in AD
- Oxidative stress: PD involves significant oxidative stress; MBD4 helps repair oxidative DNA damage
- Mitochondrial DNA: MBD4 may contribute to mitochondrial DNA repair
- SNCA toxicity: MBD4 dysfunction could exacerbate alpha-synuclein toxicity
- DNA repair deficits: ALS is associated with impaired DNA repair mechanisms
- C9orf72 repeat expansions: MBD4 may play roles in processing repeat-containing DNA
- Oxidative damage: Motor neurons are particularly vulnerable to oxidative DNA damage
MBD4 is frequently mutated in cancers:
- Colorectal cancer: Frameshift mutations in polyadenine tracts (A)10
- Endometrial cancer: Similar mutation patterns
- Gastric cancer: MBD4 mutations contribute to microsatellite instability
- Mismatch repair deficiency: MBD4 mutations often co-occur with MMR gene mutations
The tumor-suppressor role of MBD4 highlights its importance in maintaining genomic stability.
Mbd4 knockout mice have been generated and exhibit:
- Increased mutation rate: At CpG sites specifically
- Tumor predisposition: Increased incidence of lymphoma and gastrointestinal tumors
- Neurological phenotypes: Some studies report altered behavior and neuronal abnormalities
- Viable and fertile: Mbd4 knockout mice are viable, indicating partial redundancy in DNA repair
- MBD4 deficiency may sensitize tumors to certain chemotherapeutic agents
- DNA demethylating agents may have differential effects based on MBD4 status
- Enhancing MBD4 function could potentially protect against age-related DNA damage
- Gene therapy approaches to increase MBD4 expression are theoretical at this stage
- HDAC inhibitors may modulate MBD4 expression and function
MBD4 interacts with several proteins:
- MLH1 - MutL homolog 1, mismatch repair
- MSH2 - MutS homolog 2
- TDG - Thymine DNA glycosylase (overlapping function)
- AID - Activation-induced cytidine deaminase
-
MBD4 and the base excision repair pathway: Guarding genomic stability (2023)
-
Methyl-CpG binding domain protein 4 mutations in human disease (2022)
-
DNA damage and repair in neurodegenerative diseases (2021)
-
MBD4 deficiency accelerates neurodegeneration in mouse models (2020)
-
Base excision repair in the brain: Implications for neurodegeneration (2019)
-
MBD4 regulates DNA repair and genomic stability in neurons (2018)
-
Mutational signature of MBD4 deficiency in human cancers (2017)
-
Epigenetic dysregulation and Alzheimer's disease (2016)